Literature DB >> 28196020

The Prevalence and Clinicopathological Characteristics of High-Grade Pancreatic Intraepithelial Neoplasia: Autopsy Study Evaluating the Entire Pancreatic Parenchyma.

Yoko Matsuda1, Toru Furukawa, Shinichi Yachida, Makoto Nishimura, Atsuko Seki, Keisuke Nonaka, Junko Aida, Kaiyo Takubo, Toshiyuki Ishiwata, Wataru Kimura, Tomio Arai, Mari Mino-Kenudson.   

Abstract

OBJECTIVE: We sought to identify clinicopathological characteristics of high-grade pancreatic intraepithelial neoplasia (PanIN)/carcinoma in situ to facilitate screening for pancreatic ductal adenocarcinoma.
METHODS: We evaluated PanIN lesions in 173 consecutive autopsy cases with no evidence of pancreatic ductal adenocarcinoma and/or intraductal papillary mucinous neoplasm (mean age, 80.5 years) by submitting the entire pancreas for microscopic examination.
RESULTS: PanIN-3 was found in 4% of examined cases, whereas PanIN-1 and PanIN-2 were present in 77% and 28%, respectively. PanIN-3 was more frequently identified in patients with diabetes mellitus and/or older age. PanIN-3 lesions were always multifocal, and the number of PanIN-3 foci was positively associated with those of PanIN-1 or PanIN-2. PanIN-3 was located more frequently in the pancreatic body and tail than in the head and predominantly involved small interlobular/intralobular ducts rather than the main duct. Notably, 71% of pancreata with PanIN-3 showed cystic changes in PanIN-3 and lower grade PanIN lesions. PanIN-3 was also accompanied by higher grade extralobular fibrosis.
CONCLUSIONS: We found that 4% of the examined pancreata harbored PanIN-3 lesions that were associated with several unique clinicopathological features. The cystic change along with fibrotic pancreatic parenchyma may be detected by imaging studies such as endoscopic ultrasound.

Entities:  

Mesh:

Year:  2017        PMID: 28196020     DOI: 10.1097/MPA.0000000000000786

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  24 in total

1.  Pancreatic cancer arising from the remnant pancreas after pancreatectomy: a multicenter retrospective study by the Kyushu Study Group of Clinical Cancer.

Authors:  Daisuke Hashimoto; Kota Arima; Shigeki Nakagawa; Yuji Negoro; Toshihiko Hirata; Masahiko Hirota; Masafumi Inomata; Kengo Fukuzawa; Takefumi Ohga; Hiroshi Saeki; Eiji Oki; Yo-Ichi Yamashita; Akira Chikamoto; Hideo Baba; Yoshihiko Maehara
Journal:  J Gastroenterol       Date:  2018-12-04       Impact factor: 7.527

Review 2.  The pancreatic cancer genome revisited.

Authors:  Akimasa Hayashi; Jungeui Hong; Christine A Iacobuzio-Donahue
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-04       Impact factor: 46.802

Review 3.  Cellular determinants and therapeutic implications of inflammation in pancreatic cancer.

Authors:  Meredith L Stone; Gregory L Beatty
Journal:  Pharmacol Ther       Date:  2019-05-31       Impact factor: 12.310

4.  Genome-Wide Somatic Copy Number Alterations and Mutations in High-Grade Pancreatic Intraepithelial Neoplasia.

Authors:  Tatsuo Hata; Masaya Suenaga; Luigi Marchionni; Anne Macgregor-Das; Jun Yu; Koji Shindo; Koji Tamura; Ralph H Hruban; Michael Goggins
Journal:  Am J Pathol       Date:  2018-04-22       Impact factor: 4.307

5.  Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis.

Authors:  Takashi Muraki; Kee-Taek Jang; Michelle D Reid; Burcin Pehlivanoglu; Bahar Memis; Olca Basturk; Pardeep Mittal; David Kooby; Shishir K Maithel; Juan M Sarmiento; Kathleen Christians; Susan Tsai; Douglas Evans; Volkan Adsay
Journal:  Mod Pathol       Date:  2021-09-13       Impact factor: 7.842

Review 6.  Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data.

Authors:  Ashton A Connor; Steven Gallinger
Journal:  Nat Rev Cancer       Date:  2021-11-17       Impact factor: 60.716

Review 7.  Early detection of pancreatic cancer using DNA-based molecular approaches.

Authors:  Aatur D Singhi; Laura D Wood
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-07       Impact factor: 46.802

Review 8.  Cancer biology as revealed by the research autopsy.

Authors:  Christine A Iacobuzio-Donahue; Chelsea Michael; Priscilla Baez; Rajya Kappagantula; Jody E Hooper; Travis J Hollman
Journal:  Nat Rev Cancer       Date:  2019-09-13       Impact factor: 60.716

9.  mAb Das-1 identifies pancreatic ductal adenocarcinoma and high-grade pancreatic intraepithelial neoplasia with high accuracy.

Authors:  Koushik K Das; Jeffrey W Brown; Carlos Fernandez Del-Castillo; Tiffany Huynh; Jason C Mills; Yoko Matsuda; Kiron M Das; Mari Mino-Kenudson
Journal:  Hum Pathol       Date:  2021-01-30       Impact factor: 3.466

Review 10.  The biology of pancreatic cancer morphology.

Authors:  Oliver G McDonald
Journal:  Pathology       Date:  2021-12-03       Impact factor: 5.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.